Genomic insights into ceftazidime resistance in Burkholderia pseudomallei : discovery of A172T mutation and palindromic GC-rich repeat sequences facilitating penA duplication and amplification
Antimicrobial Agents and Chemotherapy · 2025
DOI: 10.1128/aac.00220-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Apichai Tuanyok und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Immunology, College of Veterinary Medicine, University of Florida, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Burkholderia pseudomallei, Ceftazidime, Anti-Bacterial Agents, Bacterial Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Japan Agency for Medical Research and Development, CRDF Global.
Abstract (Originalsprache)
Ceftazidime (CAZ) resistance in Burkholderia pseudomallei , the causative agent of melioidosis, complicates treatment in endemic regions. This study identified a novel A172T mutation and other known penA mutations as critical contributors to CAZ resistance in a large Thai strain collection. Frequent gene duplication and amplification of penA , likely driven by Palindromic GC-Rich Repeat Sequences, highlights the urgent need for rapid diagnostics and optimized treatment strategies to manage this life-threatening disease effectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases and Immunology, College of Veterinary Medicine, University of Florida, Gainesville, Florida, USA.
- Emerging Pathogens Institute, University of Florida, Gainesville, Florida, USA.
- Hokkaido University International Institute for Zoonosis Control, Sapporo, Hokkaido, Japan.
- Hokkaido University Institute for Vaccine Research and Development, Sapporo, Hokkaido, Japan.
- Faculty of Veterinary Science, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
- Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
ORCID-Profile: Apichai Tuanyok, Chie Nakajima, Charles A Yowell, Narisara Chantratita, Kuttichantran Subramaniam, Yasuhiko Suzuki
Förderung
- Wellcome Trust
- Japan Agency for Medical Research and Development
- CRDF Global
Zitieren
APA
Tuanyok, A., Nakajima, C., Noll, T., Khan, M. S. R., Khrongsee, P., Yowell, C. A., Xiao, Y. P., Wuthiekanun, V., Chantratita, N., Heine, H., Subramaniam, K., Suzuki, Y., Limmathurotsakul, D., & Mergia, A. (2025). Genomic insights into ceftazidime resistance in Burkholderia pseudomallei : discovery of A172T mutation and palindromic GC-rich repeat sequences facilitating penA duplication and amplification. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00220-25
Vancouver
Tuanyok A, Nakajima C, Noll T, Khan MSR, Khrongsee P, Yowell CA, et al. Genomic insights into ceftazidime resistance in Burkholderia pseudomallei : discovery of A172T mutation and palindromic GC-rich repeat sequences facilitating penA duplication and amplification. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.00220-25
BibTeX
@article{Tuanyok2025,
author = {Tuanyok, Apichai and Nakajima, Chie and Noll, Tiernan and Khan, Md Siddiqur Rahman and Khrongsee, Pacharapong and Yowell, Charles A and Xiao, Yu-Ping and Wuthiekanun, Vanaporn and Chantratita, Narisara and Heine, Henry and Subramaniam, Kuttichantran and Suzuki, Yasuhiko and Limmathurotsakul, Direk and Mergia, Ayalew},
title = {Genomic insights into ceftazidime resistance in Burkholderia pseudomallei : discovery of A172T mutation and palindromic GC-rich repeat sequences facilitating penA duplication and amplification},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2025},
doi = {10.1128/aac.00220-25}
}
EUVIMED